Subcutaneous Bortezomib for Treatment of TEMPI Syndrome

Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma

Philippe Moreau, Valérie Coiteux, Cyrille Hulin et al. · Haematologica · 2008 · 118 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Case 23-2010

Hasan Bazari, Eyal C. Attar, Douglas M. Dahl et al. · New England Journal of Medicine · 2010 · 41 citations

Medicine, Nephrology, Radiology +9

A new case of TEMPI syndrome

F. Mohammadi, Michael Wolverson, Bahar Bastani · Clinical Kidney Journal · 2012 · 23 citations · Full text

Medicine, Internal Medicine, Pathology +6

Perirenal fluid collections and monoclonal gammopathy

Denis Viglietti, J.-M. Sverzut, M.N. Peraldi · Nephrology Dialysis Transplantation · 2011 · 22 citations · Full text

Medicine, Nephrology, Pathology +7

Bortezomib Administered Subcutaneously Is Well Tolerated in Bortezomib-Based Combination Regimens Used in Patients with Multiple Myeloma

Wolfgang Lamm, B. Drach-Schauer, Sandra Eder et al. · Oncology · 2013 · 16 citations

Pharmacy, Pharmacology, Pharmacotherapy +14